Dr. Jamie Leigh Dipietro, DO, MBA

Dr. Dipietro practices at Chestnut Surgery Center in Fresno, California.

Dr. Dipietro's NPI, 1740477850, was assigned on October 2, 2007. Dr. Dipietro graduated from Pcom in 2005. Dr. Dipietro holds California license 20A11764.

Dr. Dipietro's primary practice is Chestnut Surgery Center, at 7014 N Whitney Ave Ste B, Fresno, CA 93720. The practice phone is (559) 321-2898.

Dr. Dipietro's primary practice is Chestnut Surgery Center in Fresno, California. Dr. Dipietro is also affiliated with Saint Agnes Medical Center. The medical group on file is Urology Associates of Central California. Dmand AI also links Dr. Dipietro to 2 more hospitals, 1 home health agency and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dipietro practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Dipietro's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Dipietro is board certified in urological surgery by the AOA Board of Surgery. Dr. Dipietro is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, erectile dysfunction, kidney cysts, kidney stone disease, pelvic prolapse, testicular dysfunction and urinary endoscopy among the conditions Dr. Dipietro treats.

CMS data shows 8,840 Medicare services from Dr. Dipietro across 30 procedure codes in 2024, for 582 Medicare patients. Medicare paid $214,555 for them.

CMS counts 582 Medicare patients who saw Dr. Dipietro in 2024. The largest group is 65 to 74, with 256 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dipietro's median patient age at 70, with 72% women.

In 2024, Dr. Dipietro wrote 1,080 Medicare Part D claims for 337 patients. 70% of them were for generic drugs. CMS names the drug for 944 of them, across 21 drugs with 11 or more claims each, at $264,371 in total drug cost. In 2023, CMS named 817 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Dipietro for performance year 2024, reported as part of a group. Dr. Dipietro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dipietro as offering telehealth.

CMS Open Payments shows 543 general payments to Dr. Dipietro from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Medtronic USA, Inc. paid the most, $6,614.

Dr. Dipietro graduated from Pcom in 2005. Dr. Dipietro is a member of AMA, AOA and AUA.

Dr. Dipietro is in network with 10 carriers, including Aetna, United Healthcare and Humana. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.